GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Net Income

Lifeline Scientific (LSE:LSI) Net Income : £9.52 Mil (TTM As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Lifeline Scientific's Net Income for the six months ended in Jun. 2016 was £1.36 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2016 was £9.52 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Lifeline Scientific's Earnings per Share (Diluted) for the six months ended in Jun. 2016 was £0.07.


Lifeline Scientific Net Income Historical Data

The historical data trend for Lifeline Scientific's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Net Income Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.23 -0.13 1.74 2.26 8.22

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 2.24 0.06 8.16 1.36

Lifeline Scientific Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Lifeline Scientific's Net Income for the fiscal year that ended in Dec. 2015 is calculated as

Net Income(A: Dec. 2015 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=3.782+4.44+0+-0.0010000000000012
=8.22

Lifeline Scientific's Net Income for the quarter that ended in Jun. 2016 is calculated as

Net Income(Q: Jun. 2016 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=1.422+-0.059+0+0.0010000000000001
=1.36

Net Income for the trailing twelve months (TTM) ended in Jun. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £9.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeline Scientific  (LSE:LSI) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Lifeline Scientific's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Lifeline Scientific Net Income Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.